Who Generates Higher Gross Profit? Viatris Inc. or Perrigo Company plc

A Tale of Two Companies: Viatris Inc. vs. Perrigo Company plc

In the competitive landscape of the pharmaceutical industry, Viatris Inc. and Perrigo Company plc have been vying for dominance in gross profit generation over the past decade. From 2014 to 2023, Viatris consistently outperformed Perrigo, with an average gross profit nearly three times higher. Notably, in 2022, Viatris achieved its peak, generating a gross profit of approximately 6.5 billion, marking a 77% increase from its 2014 figures. In contrast, Perrigo's highest gross profit was recorded in 2016, with a modest 2.1 billion, reflecting a 42% growth from 2014. Despite fluctuations, Viatris maintained a steady upward trend, while Perrigo experienced more volatility. This data underscores Viatris's robust financial strategy and market positioning, making it a formidable player in the industry. As the market evolves, these insights provide a glimpse into the strategic maneuvers of these pharmaceutical giants.